General Information
Version
4.1
Revision date
2018-03-29
Product name
ZOLADEX FOR DEPOT/IMPLANT
Product Synonyms
Zoladex 3.6 mg and 10 mg
CAS No.
145781-92-6
1.2.1 Relevant identified uses
Zoladex 3.6 mg , Management of (i) Prostate cancer (ii) Breast cancer (iii) Endometriosis (iv) Uterine fibroids (v) Endometrial thinning (vi) Assisted reproduction, ;, Zoladex 10.8 mg , Management of (i) Prostate cancer (ii) Endometriosis (iii) Uterine fibroids
supplier name
ASTRAZENECA PTY LTD
Emergency telephone
+44 (0) 1235 239 670
Icons in SDS
Company Information
company name
ASTRAZENECA PTY LTD
e-mail address of the competent person responsible for the Safety Data Sheet
SafetyDataSheets.AlderleyPark@astrazeneca.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
Section 2
SECTION 2: Hazards identification
GHS Classification Reproductive toxicity Category 1B
Signal word
Danger
Hazard statements
H360 May damage fertility or the unborn child.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P281 Use personal protective equipment as required.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
Goserelin acetate
Other hazards which do not result in classification
See Section 11.
2.1 Classification of the substance or mixture
Reproductive toxicity
